Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

ClinicalTrials.gov ID: NCT00825227

Public ClinicalTrials.gov record NCT00825227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the Safety and Efficacy of Armodafinil Treatment for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents

Study identification

NCT ID
NCT00825227
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cephalon
Industry
Enrollment
10 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Sep 30, 2009
Completion
Jan 31, 2010
Last update posted
Nov 16, 2017

2008 – 2010

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Northwest Alabama Cancer Center Muscle Shoals Alabama 35661 —
Saint Joseph Medical Center Burbank California 91505 —
Compassionate Cancer Center Fountain Valley California 92708 —
Wilshire Oncology La Verne California 91750 —
Compassionate Cancer Center Riverside California 92501 —
Scripps Cancer Center San Diego California 92123 —
Washington Cancer Institute Washington D.C. District of Columbia 20010 —
Integrated Community Oncology Network Jacksonville Florida 32256 —
Southeastern Gynecologic Oncology, LLC Atlanta Georgia 30342 —
Augusta Oncology Augusta Georgia 30901 —
Medical College of Georgia Augusta Georgia 30912 —
Summit Cancer Center Savannah Georgia 31405 —
Ingalls Cancer Research Center Harvey Illinois 60426 —
Iowa Blood and Cancer Care PLC Cedar Rapids Iowa 52402 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Frederick Memorial Hospital Frederick Maryland 21701 —
Park Nicollet Institute Saint Louis Park Minnesota 55426 —
Hematology Oncology Centers of the Northern Rockies Billings Montana 59101 —
Montana Cancer Institute Missoula Montana 59802 —
Sparta Cancer Center Sparta New Jersey 17871 —
Forsyth Regional Cancer Center Winton North Carolina 27103 —
Cancer Care Associates Tulsa Oklahoma 74136 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Mount Nittany Medical Center State College Pennsylvania 16803 —
Chester County Hospital West Chester Pennsylvania 19380 —
Charleston Hematology Oncology, PA Charleston South Carolina 29403 —
C. Michael Jones Germantown Tennessee 38138 —
McLeod Cancer and Blood Center Johnson City Tennessee 37604 —
Cancer Outreach Assoc. / Outreach Clinical Trial Consortium Abingdon Virginia 24211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00825227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2017 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00825227 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →